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Analyzed epidemiological data and nozological aspects condi-
ional by reﬁning them statistically.
Results: Of 284 cases with Zoster 67 (23.59%) were opportunis-
ic forms of its unrelated with HIV.
From them 60.87% were male and 39.13% female.
Cases according to ages: 14-20 years old 2, 21-30 years old 13,
1-40 years old 14, 41-50 years old 9, 51-60 years old 12, 61-70
ears old 15, 71 years old and over 7cases.
Distribution based on season: 19 in spring, 16 in summer, 17 in
all and 15 in winter.
Immunosuppressive causes:
infectious in 6 cases: visceral leishmaniasis 3, TB 3 (pulmonary 2,
meningitis 1);
non infectious in 61 cases: tumors 25 (stomach-3, intestinal-2,
liver-3, kidney-2, lungs-4, ovarian-2, breast-7, prostate-1, cervix-
1), lymphoma 8 (Hodgkin 3, non Hodgkin 5), leukemia 2 (chronic
myeloid -1, hair cell leukemia-1); aplastic anemia-2; cholageno-
sis 6 (SLE-2, RA- 4) , immunodeﬁc¸iens mixte 1; post transplanted
condition 3 (kidney-2, mielotransplant-1); chronic pathologies
9 (arcoidosis-1, diabetes mellitus-3, hepatic cirrhozis-1, chronic
renal insufﬁciency -1, cardiac insufﬁciency- 2 ,celiac diseases-1);
immunosuppressive therapy 5
Conclusion:
a. Opportunistic Zoster unrelated with HIV was encountered in
23.59%.
. Appeared often on males, 60.8% and ages 21 - 70 years old,
89.13%.
c. Noticed 29 conditions factor : 3 infectious, 14 tumors, 3 immune,
1 drugs, 2 after transplant, 6 in chronic pathologies.
. In 26.86% of cases, zoster preceded unknown tumoral disease.
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redictors of duration and degree of third space ﬂuid accumu-
ation in adult patients with dengue
. Premaratna1, A. Ragupathy2, N. Miththinda2,∗, J. de Silva1
Faculty of Medicine University of Kelaniya, Ragama, Sri Lanka
Colombo North Teaching Hospital, Ragama, Sri Lanka
Background: Fluid leakage is the hallmark of dengue shock
yndrome. It is important to identify clinical and biochemical
arameters which predict duration and degree of ﬂuid leakage in
engue.
Methods: 102 patients with conﬁrmed dengue were prospec-
ively followed up for clinical, haematological and biochemical
arameters, and those were correlated with ultrasonographic evi-
ence of third space ﬂuid accumulation (TSFA).
Results: Of the 102 patients (52 males; mean age 28.3 years (SD
1.8), TSFA was detected in 34/95(36%) after hospital admission;
3/95 had pleural effusions which included all except one of 21/95
ho had ascites. The majority of pleural effusions (72.7%) lasted 3
r more days and in most cases (52.4%) ascites lasted less than 3
ays.nfectious Diseases 16S (2012) e2–e157
Duration of pleural effusion showed a signiﬁcant positive
correlation with severity of body aches (assessed on a visual ana-
logue scale) (r=0.523, p=0.001), maximum percentage rise of PCV
(r=0.526, p=0.001) and maximum percentage rise of Hb (r=0.525,
p=0.001). It was negatively correlated with WBC count (r= -
0.361, p=0.020) and platelet count (r= -0.585, p=0.000). There
was no correlation with admission weight (p=0.125), duration of
fever (p=0.387), lowest pulse pressure (p=0.299), ALT(p=0.241),
AST(p=0.328), average ﬂuid intake per day (p=0.118) and ﬂuid bal-
ance per day (p=0.129).
The mean lowest WBC count of 3005/mm3 that was recorded
for patients who developed bilateral pleural effusions (n=21) was
signiﬁcantly less (p=0.042) than the mean lowest WBC count of
4091/mm3 that was detected for unilateral effusions (n=12). There
was no signiﬁcant difference in other parameters between these 2
groups.
Duration of ascites was signiﬁcantly positively correlated with
highest AST (r=0.598, p=0.002) and highest ALT (r=0.721, p=0.000).
Conclusion: Severity of body aches on detecting effusions,max-
imumpercentage riseofHbandPCV, lowerWBCandplatelet counts
seem to be associated with longer periods of TSFA. Among these,
lower WBC counts appear to be more predictive of the degree of
ﬂuid leakage. Higher ALT and AST levels seem to be useful in pre-
dicting the duration of ascites.
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The epidemiology of hepatitis C virus in Egypt: a systematic
review
Y. Mohamoud ∗, G. Mumtaz, L. Abu-Raddad
Weill Cornell Medical College in Qatar, Doha, Qatar
Background: Egypt has the highest prevalence of hepatitis C
virus (HCV) in the world, estimated nationally at 14.7%. This nation
has weathered the largest iatrogenic transmission epidemic of
blood-borne pathogens in human history during the era of par-
enteral antischistosomal therapy (PAT). NumerousHCV prevalence
studies have published various estimates from different Egyptian
communities, suggesting that Egypt, relative to the other nations
of the world, might be experiencing intense ongoing HCV trans-
mission. This review’s objective was to delineate the evidence on
the epidemiology of HCV transmission among the different at risk
population groups.
Methods: This was a systematic review following the PRISMA
guidelines of all data on HCV transmission in Egypt. Sources of data
includedPubMed, Embase, international organizations’ reports and
databases, and country-level reports and databases.
Results: Five studies have measured HCV incidence in Egypt.
HCV incidence among village residents ranged between 2.4/1,000
person-years and 5.2/1,000 person-years. On the other hand, 130
studies have measured HCV prevalence among populations at
varying levels of risk. Among Egypt’s general population, HCV
prevalence in pregnant women was as high as 15.8%, and among
blood donors it ranged between 9.0% and 24.8%. A national survey
recently measured an overall prevalence of 14.7%. Among popula-
tions at direct risk of exposure, HCV prevalence was found to be
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shown that Adacolumn changed the cellular immunity and pro-
moted an early virological response.
http://dx.doi.org/10.1016/j.ijid.2012.05.23015th ICID Abstracts / International Journ
s high as 58.2% in multi-transfused children, 51.6% in children on
emodialysis and 87.5% in adult dialysis patients. Among popula-
ions at indirect risk, family contacts of HCV positive individuals
ad a prevalence of 5.7%, diabetic children a prevalence of 3.1%,
elect professions such as barbers 12.3%, and health care workers
5.7%, while Injection drug users and prisoners had a prevalence
f 63% and 31.4%, respectively. Common risk factors appear to
e increasing age, parenteral anti-schistosomal therapy, frequent
ransfusions, injections or surgical procedures.
Conclusion: With the highest HCV prevalence in the world,
gypt appears to be experiencing an HCV epidemic. High HCV
revalence levels especially among select clinical populations, is
ndicative of ongoing iatrogenic transmission. Therefore, preven-
ion programs need to be developed targeting HCV transmission
outes suchasbetter infection control practices inhospitals, health-
are and dental care facilities.
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ersistance of HBsAg, liver enzyme changes and risk factors of
epatitis B infection among chronic carriers of hepatitis B
. Momen Heravi1,∗, H. Akbari2, Z. Soleimani3
kashan university of medical sciences, kashan, isfahan, Iran, Islamic
epublic of
kashan university of medical sciences, Kashan, Isfahan, Iran, Islamic
epublic of
infectios disease department, kashan, Iran, Islamic Republic of
Background: Hepatitis B virus (HBV) infection and its sequelae
re major global health problems. It is estimated that 400 million
eople worldwide are HBV carriers.This study was conducted to
valuateHBsAgpersistence, risk factors ofHBV infection anddetect
f HBeAg positive cases and abnormal liver enzyme tests among
hronic HBV carriers in Kashan
Methods: This descriptive study was performed in HBsAg pos-
tive blood donors who detected after blood donation during 10
ears ago. They were invited to retest HBsAg. After obtaining con-
ent form a questionnaire consisting demographic and history of
isk factors of HBV infection were ﬁlled by interviewing and then
cc blood was taken from cases and HBsAg was measured by ELISA
ethod. Who had HBsAg positive test HBeAg, liver enzyme tests
eremeasured .The results were analyzed by SPSS,ﬁsher exact and
test.
Results: Of 150 HBsAg positive blood donors 124(83.7%) were
ale and26(17.3%) female. Persistence and clearance ofHBsAgwas
een in 132(88%) and18(12%)respectovely .There was no signiﬁ-
ant statistical correlation between sex, age,marital status, history
f icther,endoscpy,tattoo.transfusion,with persistence of HBsAg .(P
alue>0.05)
HBeAg was positive in 18.2% of HBsAg positive cases. There was
bnormal aminotransferase There was no statistical correlation
etween ALT, AST and ALKP with HBeAg (P value>0.05) .Chronic
epatitis B was detected in three patient.
Conclusion: Considering the lower rate of clearance of
BsAg,and also detecting of suspected cases of chronic hepati-
is,determine of HBeAg state and periodic examination of livernfectious Diseases 16S (2012) e2–e157 e99
enzyme test seems to be essential in follow up in chronic HBV
carriers.
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Leukocytapheresis treatment for recurrenceVirus C infection in
liver transplant recipients
V. Morabito ∗, G. Ferretti, M. Rossi, G. Novelli
Sapienza University, Rome, Italy
Background: In liver transplant (LT) recipients, persistence of
hepatitis C (HCV) infection in viremic recipients almost always
leads to graft reinfection. Although HCV is a hepatocellular
pathogen, there is increasing evidence that the virus can infect
and persist in other cells. In particular, granulocytes and mono-
cytes/macrophages are known to constitute extra-hepatic sites for
HCV replication and dissemination. The aim of this study was to
apply Adacolumn apheresis as a possible therapeutic alternative to
conventional drug therapy in the management of HCV infection.
Methods: Seven patients who received liver transplantation for
Virus C-related cirrhosis were eligible for the study. The patients
underwent ﬁve 1-hour sessions for 5 consecutive days. First treat-
ment was performed in the anhepatic phase of liver transplant
with the intent to early reduce infected granulocytes and mono-
cytes/macrophages. The patients were evaluated during the 5 days
after inclusion with and 6-month follow-up.
Results: Early apheretic treatment in anhepatic phase and for
the following 4 days after transplant determined low viral load in
four LT patients, negative viral load in two patients and an increase
in viremia values in one patient. At follow up the viremia load was
stable in 7 patients without an increase of transaminases levels. At
the end of treatment cycle almost all immune cells of six patients
showed maintained CD4+/CD8+ T cells ratio.
Conclusion: The optimal timing of treatment initiation is
unknown, but an early preemptive therapy is recommended to
decrease the risks for recurrence of infection. Although this study
investigated the responses in a small number of patients, it was
